Actively Recruiting
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
Led by Baylor Research Institute · Updated on 2026-03-16
10000
Participants Needed
8
Research Sites
1565 weeks
Total Duration
On this page
Sponsors
B
Baylor Research Institute
Lead Sponsor
T
Translational Genomics Research Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of the Texas Immuno-Oncology Biorepository (TIOB) is to collect and store well-defined and well-annotated serial biospecimens of tissue, blood, urine and stool in a longitudinal manner from cancer patients who are receiving either standard of care surgical interventions and or FDA approved immunotherapeutics across the largest not-for-profit health system in Texas. Comprehensive clinical and radiological data from a diverse population of patients with different racial, social and ethnic backgrounds matched with serial biospecimens over a patients journey with cancer marks the TIOB as a unique research facility.
CONDITIONS
Official Title
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant is over 18 years of age at the time of signing the informed consent form.
- Participant is able and willing to sign an informed consent form.
- Participant is suspected by a provider of being at risk for developing cancer, OR has confirmed or clinically suspected malignancy.
- Participants may be candidates for or scheduled to receive standard of care immunotherapy treatment for the first time for their current cancer diagnosis.
- Participants may be enrolled in a clinical trial to receive a novel immunotherapy drug for the first time for their current cancer diagnosis.
- Participants may be surgical candidates for their current cancer diagnosis, regardless of any prior treatment.
You will not qualify if you...
- Participant is unable or unwilling to donate blood.
- Participant has a medical or psychiatric condition that prevents giving informed consent or interferes with study procedures or results.
- Investigator believes participation would pose a hazard due to the participant's health.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 8 locations
1
Baylor Scott & White Medical Center - College Station
College Station, Texas, United States, 77845
Actively Recruiting
2
Baylor University Medical Center - Dallas
Dallas, Texas, United States, 75246
Actively Recruiting
3
Baylor Scott & White All Saints Medical Center - Fort Worth
Fort Worth, Texas, United States, 76104
Actively Recruiting
4
Baylor Scott & White Medical Center - Plano
Plano, Texas, United States, 75093
Actively Recruiting
5
Baylor Scott & White Medical Center - Round Rock
Round Rock, Texas, United States, 78665
Actively Recruiting
6
Baylor Scott & White Medical Center - Temple
Temple, Texas, United States, 76508
Actively Recruiting
7
Baylor Scott & White Medical Center - Hillcrest
Waco, Texas, United States, 76712
Actively Recruiting
8
Baylor Scott & White Medical Center - Waxahachie
Waxahachie, Texas, United States, 75165
Actively Recruiting
Research Team
P
Pukar Ratti, MSChE, MSHCM
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here